rs80356704
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PP2PP3_ModeratePP5_Very_Strong
The NM_000083.3(CLCN1):c.1592C>T(p.Ala531Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A531T) has been classified as Uncertain significance.
Frequency
Consequence
NM_000083.3 missense
Scores
Clinical Significance
Conservation
Publications
- myotonia congenita, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myotonia congenita, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Thomsen and Becker diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLCN1 | ENST00000343257.7 | c.1592C>T | p.Ala531Val | missense_variant | Exon 15 of 23 | 1 | NM_000083.3 | ENSP00000339867.2 | ||
| CLCN1 | ENST00000432192.6 | n.*877C>T | non_coding_transcript_exon_variant | Exon 15 of 23 | 1 | ENSP00000395949.2 | ||||
| CLCN1 | ENST00000432192.6 | n.*877C>T | 3_prime_UTR_variant | Exon 15 of 23 | 1 | ENSP00000395949.2 | ||||
| CLCN1 | ENST00000650516.2 | c.1592C>T | p.Ala531Val | missense_variant | Exon 15 of 23 | ENSP00000498052.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251370 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1460858Hom.: 0 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 726802 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74478 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Published functional studies demonstrate that the variant results in a reduced amount of unstable protein (PMID: 17990293, 23424641); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26021757, 22094069, 15162127, 27580824, 11840191, 23424641, 23933576, 18807109, 21221019, 35907044, 34938096, 37355912, 38855810, 36034862, 17990293, 10430417)
PS3, PS4_moderate, PM3, PP1, PP3
Congenital myotonia, autosomal recessive form Pathogenic:3
Variant summary: CLCN1 c.1592C>T (p.Ala531Val) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 251370 control chromosomes, exclusively at a frequency of 4.4e-05 (i.e., 11 heterozygotes) within the Finnish subpopulation in the gnomAD database. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1592C>T has been reported in the literature in multiple compound heterozygous individuals affected with Congenital Myotonia, Autosomal Recessive Form (e.g., Sun_2002, Modoni_2011). Additionally, the variant was identified in several apparent heterozygotes affected with myotonia and latent myotonia, but was observed in unaffected heterozygous carriers as well, suggesting this variant may also cause autosomal dominant disease although with reduced penetrance (e.g., Sun_2002). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 21221019, 11840191). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Congenital myotonia, autosomal recessive form;C2936781:Congenital myotonia, autosomal dominant form Pathogenic:2
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 531 of the CLCN1 protein (p.Ala531Val). This variant is present in population databases (rs80356704, gnomAD 0.04%). This missense change has been observed in individual(s) with myotonia congenita (PMID: 10430417, 11840191, 21221019, 22094069, 23933576; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21040). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CLCN1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CLCN1 function (PMID: 17990293, 23424641, 23933576, 26021757, 27580824). For these reasons, this variant has been classified as Pathogenic.
Batten-Turner congenital myopathy Other:1
Associated with autosomal recessive and autosomal dominant mode of inheritance
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at